| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | Director | Option (Right to Buy) | 23,000 | $308,660 | $13.42 | 14 Jun 2023 | Direct |
| Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 30,000 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 17:45 |
| VOR | Vor Biopharma Inc. | 23 May 2024 | 1 | $0 | 4 | Director | 28 May 2024, 16:10 |
| QTTB | Homology Medicines, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:33 |
| VOR | Vor Biopharma Inc. | 26 May 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:38 |
| QTTB | Homology Medicines, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:06 |
| VOR | Vor Biopharma Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 17:11 |
| QTTB | Homology Medicines, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:40 |